Immunotherapy and the Tumor Microenvironment

The Scientist is bringing a panel of experts together to discuss advances in our understanding of the tumor microenvironment and how this knowledge is being harnessed to develop targeted therapies.

May 25, 2016
The Scientist Marketing Team

 

The tumor milieu is the site of complex interactions between immune cells, tumor cells, and the surrounding tissue. Innovative technologies and strategies are being employed to characterize these interactions to understand the role of the tumor microenvironment in tumorigenesis and metastasis. The Scientist is bringing a panel of experts together to discuss advances in our understanding of the tumor microenvironment and how this knowledge is being harnessed to develop targeted therapies. Attendees will have an opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • The role of the immune system as a mediator of the tumor microenvironment
  • Modulation of the tumor microenvironment as a means of inhibiting tumor growth and suppressing metastasis

View the Video Now

Meet the Speakers:

Douglas T. Fearon, FRS FMedSci FRCP
Professor, Cold Spring Harbor Laboratory
Walter B. Wriston Professor of Pancreatic Cancer Research, Weill Cornell Medicine
Emeritus Sheila Joan Smith Professor, University of Cambridge
Senior Group Leader, CRUK Cambridge Institute

 

Michael R. Shurin, MD, PhD 
Professor of Pathology and Immunology
Associate Director of Clinical Immunopathology
University of Pittsburgh Medical Center

 

R&D Systems